Company news
Nanjing Pharmaceutical Group Company Limited Class A (SSE:600713) news
Nanjing Pharmaceutical Group Company Limited Class A news releases on 6ix. Latest, Sep 22, 2026: "NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement…
Press releases & updates
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Redemption of the 1st Tranche of Super Short-term Commercial Paper for 2026
September 21, 2026
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Outline of the 2026 Semi-annual Performance Briefing
September 17, 2026
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026
September 15, 2026
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Implementation of Dividend Distribution for the First Half of 2026
September 9, 2026
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Redemption upon Maturity of Cash Management Products Purchased with Certain Temporarily Idle Raised Funds and Continued Cash Management by the Company and Its Subsidiary
September 8, 2026
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Convening the 2026 Semi-annual Performance Briefing
September 7, 2026
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Indicative Announcement on Suspension of Conversion of "NANJING PHARMACEUTICAL Convertible Bonds" During the Implementation of Interim Dividend Distribution for 2026
September 3, 2026
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Redemption upon Maturity of Cash Management Products Purchased with Certain Temporarily Idle Raised Funds and Continued Cash Management by the Company
September 2, 2026
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Issuance Results of the 11th Tranche of Super Short-term Commercial Paper for 2026
August 28, 2026
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on the Departure of a Non-Independent Director
August 21, 2026
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Redemption upon Maturity of Cash Management Products Purchased by the Company's Subsidiary with Part of Temporarily Idle Raised Funds and Continued Cash Management
July 15, 2026
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on the Issuance Results of the 2nd Tranche of Medium-Term Notes for 2026
July 13, 2026
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Progress in External Investment by the Controlled Subsidiary and Signing of Relevant Investment Agreements
July 10, 2026
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Resolutions of the Extraordinary Meeting of the 10th Board of Directors
July 7, 2026
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Conversion Result of Convertible Bonds and Share Changes
July 1, 2026
Announcement on Progress in Investment Cooperation with a Private Fund
June 25, 2026
Announcement on Adjusting the Total Cash Dividends for the 2025 Annual Profit Distribution
June 23, 2026
Indicative Announcement on Stopping Conversion of "NPGC Convertible Bonds" When Implementing Dividend Distribution for 2025
June 16, 2026
Announcement on Issuance Result of Phase VIII Ultra-Short-Term Financing Bonds of 2026
June 15, 2026
Announcement on Completing the Repurchase and Cancellation of Restricted Stocks without Adjusting Conversion Price of Convertible Bonds
June 9, 2026
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
June 8, 2026
Announcement on the Redemption upon Maturity of Cash Management with Part of Temporarily Idle Raised Funds by the Company’s Subsidiaries and the Continuation of Cash Management
June 4, 2026
Announcement on the Redemption upon Maturity of Cash Management with Part of Temporarily Idle Raised Funds by the Company and the Continuation of Cash Management
June 2, 2026
Announcement on Issuance Result of Phase VII Ultra-Short-Term Financing Bonds of 2026
May 28, 2026
Announcement on Issuance Result of Phase I Medium-term Notes of 2026
May 27, 2026
Announcement on Outline of the Performance Briefing for 2025 and Q1 2026
May 26, 2026
Announcement on Resolutions of the Extraordinary Meeting of the 10th Board of Directors
May 21, 2026
Announcement on Termination of Outward Investment
May 19, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
May 13, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 8, 2026
Report for Q1 2026
April 29, 2026
Announcement on Issuance Result of Phase VI Ultra-Short-Term Financing Bonds of 2026
April 13, 2026
Announcement on Progress in Government’s Expropriation of Certain Real Estate and Land of the Company’s Tier-II Subsidiary
April 10, 2026
Announcement on Election of Employee Representative Directors for the 10th Board of Directors
April 7, 2026
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
April 2, 2026
Announcement on Conversion Result of Convertible Bonds and Share Changes
April 1, 2026
Indicative Announcement on Convening the 2nd Extraordinary General Meeting in 2026
March 25, 2026
Announcement on Implementing Cancellation of Repurchased Shares and Share Changes
March 23, 2026
Announcement on the Change of Project Quality Reviewer by Audit Institution
March 17, 2026
Announcement on Issuance Result of Phase IV Ultra-Short-Term Financing Bonds of 2026
March 10, 2026
Announcement on Issuance Result of Phase III Ultra-Short-Term Financing Bonds of 2026
March 9, 2026
Announcement on Progress in Use of Part of the Temporarily Idle Raised Proceeds for Cash Management by the Company and Its Subsidiaries
March 4, 2026
Announcement on Completion of Share Transfer by Shareholders Holding More than 5% of Shares
February 27, 2026
Announcement on the Redemption upon Maturity of Cash Management with Part of Temporarily Idle Raised Funds by the Company and Its Subsidiaries and the Continuation of Cash Management
February 26, 2026
Announcement on Cashing of Phase V Ultra-Short-Term Financing Bonds of 2025
February 10, 2026
Announcement on Canceling Repurchased Shares and Decreasing Registered Capital and Notification to Creditors
February 5, 2026
Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2026
January 28, 2026
Announcement on Unlocking and Listing of Stocks in 3rd Trade Restriction Release Period for the First Granted Part of the 2021 Restricted Stock Incentive Plan
January 26, 2026
Announcement on Cashing of Phase III Ultra-Short-Term Financing Bonds of 2025
January 20, 2026
Announcement on Issuance Result of Phase I Ultra-Short-Term Financing Bonds of 2026
January 19, 2026